Sherry Shi

Overall survival in patients with glioblastoma before and after bevacizumab approval

Derek R. Johnson, Antonio Omuro, Arliene Ravelo et al. · Current Medical Research and Opinion · 2017 · 42 citations

Medicine, Oncology, Medical Oncology +15

Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations

Eytan M. Stein, Gaetano Bonifacio, Dominick Latrémouille-Viau et al. · Journal of Medical Economics · 2018 · 42 citations · Full text

Medicine, Oncology, Pharmacoeconomics +15

Economic burden of relapse/recurrence in patients with major depressive disorder

Geneviève Gauthier, Lisa Mucha, Sherry Shi et al. · Journal of Drug Assessment · 2019 · 36 citations · Full text

Pharmacy, Pharmacoeconomics, Psychiatry +17

Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States

Michael L. Volk, Rebecca Burne, Annie Guérin et al. · Journal of Medical Economics · 2021 · 28 citations · Full text

Medicine, Internal Medicine, Pharmacoeconomics +17

Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease

Haridarshan Patel, Dominick Latrémouille-Viau, Rebecca Burne et al. · Crohn s & Colitis 360 · 2019 · 26 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +10